Model
Edge
4D Molecular Therapeutics
0001920738
Filing Type
4
Filing Date
11/18/2025
Updated
11/19/25, 7:53 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership